Skip to main content
. 2017 Aug 31;46(1):348–356. doi: 10.1177/0300060517726441

Figure 1.

Figure 1.

Relative serum urothelial carcinoma-associated 1 (UCA1) expression levels and their diagnostic value in patients with hepatocellular carcinoma (HCC). (a) The expression of serum UCA1 was significantly higher in patients with HCC than in patients with benign liver disease (BLD) and healthy controls (HCs). (b) Receiver operating characteristic (ROC) curve analysis of serum UCA1 for discriminating patients with HCC from HCs. (c) ROC curve analysis of serum UCA1 for discriminating patients with HCC from patients with BLD.